Structure-activity relationship of the aminomethylcyclines and the discovery of omadacycline.
about
The Novel Aminomethylcycline Omadacycline Has High Specificity for the Primary Tetracycline-Binding Site on the Bacterial RibosomeEndless Resistance. Endless Antibiotics?Antibiotics in the clinical pipeline at the end of 2015.In Vitro and In Vivo Activity of Omadacycline against Two Biothreat Pathogens, Bacillus anthracis and Yersinia pestis.Impact of growth matrix on pharmacodynamics of antimicrobial drugs for pig pneumonia pathogens.Effect of Food on the Bioavailability of Omadacycline in Healthy Participants.Omadacycline: development of a novel aminomethylcycline antibiotic for treating drug-resistant bacterial infections.Recent Advances in the Rational Design and Optimization of Antibacterial Agents.Pharmacokinetic/pharmacodynamic integration and modelling of oxytetracycline for the porcine pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects.Surveillance of Omadacycline Activity against Clinical Isolates from a Global Collection (North America, Europe, Latin America, Asia-Western Pacific), 2010-2011.In Vivo Pharmacodynamic Evaluation of Omadacycline (PTK 0796) against Streptococcus pneumoniae in the Murine Pneumonia Model.Activities of Omadacycline and Comparator Agents against Staphylococcus aureus Isolates from a Surveillance Program Conducted in North America and Europe.What is the true in vitro potency of oxytetracycline for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida?Actinomycetes: still a source of novel antibiotics.Pharmacokinetics and Safety of Omadacycline in Subjects With Impaired Renal Function.Natural Products as Platforms To Overcome Antibiotic Resistance.Safety and Pharmacokinetics of the Aminomethylcycline Antibiotic Omadacycline Administered to Healthy Subjects in Oral Multiple-Dose Regimens.Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program.
P2860
Q28818623-DECF6E79-023D-4E57-8AE2-A95D9CCCA5D1Q28822179-E44B2E77-A62C-4EFC-8E2E-4EAD861B7A71Q30249262-AF65F1ED-944F-4AD8-878E-7BDA4B6DCB5DQ33601803-E29D248F-8D69-4EBC-8E08-004D9B46D727Q36413575-C0DAD20B-6F2D-41B4-A5FD-A7D3A0280B84Q37664108-F8E8A463-84F8-4483-AF71-A94551BCE205Q37835462-F2C8009C-F34B-4613-88CC-F5632D251A2CQ38958278-8BEABE16-F520-4B81-B3B7-1ACCCE89A112Q39019096-EA711311-B5AB-47F1-BF3B-D0ABCC71CAB2Q40140013-5A4E75E2-9E9D-4FD5-AD6F-2A0C56BB6F74Q40323052-B9F60B9D-6CA4-4D20-8D6D-24103908D617Q40334499-61F4C90E-D8A0-49C2-8D8E-45517D536DCAQ40403783-F7E83C53-AD50-4930-9AFF-1FF7CA378A1DQ42359420-3BBC4A46-1C8D-44BD-969A-2B7B495F7980Q46319269-5B91E73B-41F8-49FB-B758-E264579F1EADQ47439634-CA2C4194-141C-4AE2-8359-7F44CE5C4721Q48281604-48F4226D-5F13-41B8-86B8-E8E1E46DA5AFQ49587227-5A13057F-9E1D-4BC3-B2B8-355C11E9FC20Q49598780-F3419E60-3044-4F99-B74C-B4810951FFD8
P2860
Structure-activity relationship of the aminomethylcyclines and the discovery of omadacycline.
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Structure-activity relationshi ...... the discovery of omadacycline.
@ast
Structure-activity relationshi ...... the discovery of omadacycline.
@en
Structure-activity relationshi ...... the discovery of omadacycline.
@nl
type
label
Structure-activity relationshi ...... the discovery of omadacycline.
@ast
Structure-activity relationshi ...... the discovery of omadacycline.
@en
Structure-activity relationshi ...... the discovery of omadacycline.
@nl
prefLabel
Structure-activity relationshi ...... the discovery of omadacycline.
@ast
Structure-activity relationshi ...... the discovery of omadacycline.
@en
Structure-activity relationshi ...... the discovery of omadacycline.
@nl
P2093
P2860
P356
P1476
Structure-activity relationshi ...... the discovery of omadacycline.
@en
P2093
Ann Macone
Atul K Verma
Beena Bhatia
E Pat Cannon
Jackson Chen
Kwasi Ohemeng
Laura Honeyman
Mark L Nelson
Mohamed Ismail
Rachid Mechiche
P2860
P304
P356
10.1128/AAC.01536-15
P407
P577
2015-09-08T00:00:00Z